Literature DB >> 19393753

Effect of FK506 and cyclosporine A on the expression of BDNF, tyrosine kinase B and p75 neurotrophin receptors in astrocytes exposed to simulated ischemia in vitro.

Bozena Gabryel1, Jacek Bernacki.   

Abstract

We investigated whether the immunosuppressive drugs, FK506 and cyclosporine A, increase BDNF protein and/or mRNA expression in ischemic astrocytes and if an increase could be related to changes in the nuclear expression of p-CREB, p-Erk1/2 and p-Akt. The influence of these immunosuppressants on protein and mRNA levels of TrkB and p75(NTR) receptors was also examined. On day 21, cultures of rat astrocytes were subjected to ischemic conditions simulated in vitro (combined oxygen glucose deprivation, OGD) for 8h and exposed to FK506 (10-1000nM) and cyclosporine A (0.25-10microM). FK506 and cyclosporine A (at 1000nM and 0.25microM, respectively) stimulated the expression and release of BDNF in cultured rat cerebral cortical astrocytes exposed to OGD. The immunosuppressants at these doses simultaneously increased p-CREB and p-Erk1/2 expression in the nuclear fraction of astrocytes. The results RT-PCR and Western blot analysis provided further evidence of a modulating influence of the drugs on the expression of trkB and p75(NTR) genes and their protein products in ischemic astrocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393753     DOI: 10.1016/j.cellbi.2009.04.006

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  5 in total

1.  Chronic administration of cyclosporine A changes expression of BDNF and TrkB in rat hippocampus and midbrain.

Authors:  Chien-Chih Chen; Li-Wen Hsu; Li-Tung Huang; Tiao-Lai Huang
Journal:  Neurochem Res       Date:  2010-04-02       Impact factor: 3.996

2.  CNS Delivery and Anti-Inflammatory Effects of Intranasally Administered Cyclosporine-A in Cationic Nanoformulations.

Authors:  Sunita Yadav; Grishma Pawar; Praveen Kulkarni; Craig Ferris; Mansoor Amiji
Journal:  J Pharmacol Exp Ther       Date:  2018-12-27       Impact factor: 4.030

3.  Expression of brain-derived neurotrophic factor in kidneys from normal and cyclosporine-treated rats.

Authors:  Yuan Sheng Tao; Shang Guo Piao; Ying Shun Jin; Ji Zhe Jin; Hai Lan Zheng; Hai Yan Zhao; Sun Woo Lim; Chul Woo Yang; Can Li
Journal:  BMC Nephrol       Date:  2018-03-14       Impact factor: 2.388

4.  The Effect of Maintenance Treatment with Twice-Daily or Prolonged Once-Daily Tacrolimus Formulation on Visual Evoked Potentials in Stable Kidney Transplant Recipients.

Authors:  Aureliusz Kolonko; Małgorzata Jurys; Sebastian Sirek; Tomasz Dwulit; Dorota Pojda-Wilczek; Andrzej Więcek
Journal:  J Clin Med       Date:  2020-06-11       Impact factor: 4.241

5.  Neurotrophic interactions between neurons and astrocytes following AAV1-Rheb(S16H) transduction in the hippocampus in vivo.

Authors:  Min-Tae Jeon; Gyeong Joon Moon; Sehwan Kim; Minji Choi; Yong-Seok Oh; Dong Woon Kim; Hyung-Jun Kim; Kea Joo Lee; Youngshik Choe; Chang Man Ha; Il-Sung Jang; Michiko Nakamura; Catriona McLean; Won-Suk Chung; Won-Ho Shin; Seok-Geun Lee; Sang Ryong Kim
Journal:  Br J Pharmacol       Date:  2019-12-27       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.